Completed NA INTERVENTIONAL 3-arm NCT03286777

Increasing the Oral Bioavailability of 6-prenylnaringenin by Micellar Solubilization

Sponsor: University of Hohenheim

Conditions PBMC Activity After Native vs. Micellar 6-PN Oral Intake Pharmacokinetics of Native vs. Micellar 6-PN After Oral Intake Safety of Native vs. Micellar 6-PN After Oral Intake

Interventions Micellar 6-prenylnaringenin Native 6-prenylnaringenin Placebo

Updated 7 times since 2017 Last updated: Oct 9, 2018 Started: Jun 22, 2017 Primary completion: Dec 31, 2017 Completion: Jul 1, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on PBMC Activity After Native vs. Micellar 6-PN Oral Intake and Pharmacokinetics of Native vs. Micellar 6-PN After Oral Intake, this trial is completed. The trial is conducted by University of Hohenheim and has accumulated 7 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Nov 2018 — Jan 2021 [monthly]

Completed NA

Status: Active Not Recruiting → Completed
Jun 2018 — Nov 2018 [monthly]

Active Not Recruiting NA

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Active Not Recruiting NA
Oct 2017 — Apr 2018 [monthly]

Active Not Recruiting NA

First recorded

Jun 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Hohenheim
Universität Tübingen

Data source: University of Hohenheim

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Stuttgart, Germany
• Tübingen, Germany